Sino-Argi Leading Biosciences (603970) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) has a cash flow conversion efficiency ratio of -0.227x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-390.12 Million ≈ $-57.09 Million USD) by net assets (CN¥1.72 Billion ≈ $251.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sino-Argi Leading Biosciences balance sheet independence to measure how much of total assets are equity-financed.
Sino-Argi Leading Biosciences - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Sino-Argi Leading Biosciences's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603970 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Sino-Argi Leading Biosciences Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sino-Argi Leading Biosciences ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Xujiahui Commercial Co Ltd
SHE:002561
|
0.021x |
|
Sappi Ltd
JSE:SAP
|
0.023x |
|
Shenyang Chemical Industry Co Ltd
SHE:000698
|
0.142x |
|
Wolfspeed, Inc.
NASDAQ:WOLF
|
-0.005x |
|
Codere Online US Corp
NASDAQ:CDRO
|
0.181x |
|
Tae Kwang Corporation
KQ:023160
|
0.012x |
|
Zhongfu Information Inc
SHE:300659
|
-0.012x |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
-0.094x |
Annual Cash Flow Conversion Efficiency for Sino-Argi Leading Biosciences (2012–2025)
The table below shows the annual cash flow conversion efficiency of Sino-Argi Leading Biosciences from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Sino-Argi Leading Biosciences market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.73 Billion ≈ $252.90 Million |
CN¥-78.31 Million ≈ $-11.46 Million |
-0.045x | -124.80% |
| 2024-12-31 | CN¥1.68 Billion ≈ $246.23 Million |
CN¥307.40 Million ≈ $44.98 Million |
0.183x | +131.66% |
| 2023-12-31 | CN¥1.59 Billion ≈ $233.27 Million |
CN¥-919.85 Million ≈ $-134.60 Million |
-0.577x | -155.78% |
| 2022-12-31 | CN¥1.48 Billion ≈ $217.23 Million |
CN¥1.54 Billion ≈ $224.71 Million |
1.034x | +307.16% |
| 2021-12-31 | CN¥1.28 Billion ≈ $187.44 Million |
CN¥325.42 Million ≈ $47.62 Million |
0.254x | -17.50% |
| 2020-12-31 | CN¥1.14 Billion ≈ $167.32 Million |
CN¥352.12 Million ≈ $51.53 Million |
0.308x | +46.94% |
| 2019-12-31 | CN¥1.04 Billion ≈ $152.84 Million |
CN¥218.90 Million ≈ $32.03 Million |
0.210x | +205.35% |
| 2018-12-31 | CN¥957.07 Million ≈ $140.05 Million |
CN¥65.69 Million ≈ $9.61 Million |
0.069x | -88.54% |
| 2017-12-31 | CN¥866.35 Million ≈ $126.77 Million |
CN¥518.83 Million ≈ $75.92 Million |
0.599x | +69.73% |
| 2016-12-31 | CN¥431.42 Million ≈ $63.13 Million |
CN¥152.22 Million ≈ $22.27 Million |
0.353x | +147.82% |
| 2015-12-31 | CN¥344.56 Million ≈ $50.42 Million |
CN¥-254.22 Million ≈ $-37.20 Million |
-0.738x | -630.24% |
| 2014-12-31 | CN¥290.44 Million ≈ $42.50 Million |
CN¥40.41 Million ≈ $5.91 Million |
0.139x | +145.88% |
| 2013-12-31 | CN¥262.68 Million ≈ $38.44 Million |
CN¥-79.66 Million ≈ $-11.66 Million |
-0.303x | -166.96% |
| 2012-12-31 | CN¥241.63 Million ≈ $35.36 Million |
CN¥109.43 Million ≈ $16.01 Million |
0.453x | -- |
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more